Exclusive interview with conference speaker Che Connon released ahead of SMi’s Ophthalmic Drugs Conference Read more
GSK starts a phase III clinical programme for a potential first-in-class antibiotic, gepotidacin Read more
Ziopharm Oncology and MD Anderson Cancer Center Announce New R&D Agreement to Expand TCR-T Program Read more
CARsgen Announces Investigational CAR-T Therapy CT053 Granted RMAT Designation by the FDA for R/R Multiple Myeloma Read more
Gilead and Glympse Bio Announce Strategic Collaboration for Use of Biomarker Technology in NASH Clinical Development Read more